COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 1395: Articles 13941-13950  | Next

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
Albalawi, O. M., Alomran, M. I., Alsagri, G. M., Althunian, T. A., Alshammari, T. M.
10.1101/2021.07.10.21260304 — Posted: 2021-07-12 Discussion: Onsite
Predicted Norovirus Resurgence in 2021-2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study
O'Reilly, K. M., Sandmann, F., Allen, D., Jarvis, C. I., Gimma, A., Douglas, A., Larkin, L., Wong, K. L., Baguelin, M., Baric, R. S., Lindesmith, L., Goldstein, R. A., Breuer, J., Edmunds, W. J.
10.1101/2021.07.09.21260277 — Posted: 2021-07-12
Risk of Severe COVID-19 Outcomes Among Patients with Rheumatoid Arthritis in the United States
Chuo, C.-Y., Yau, V., Madhavan, S., Tsai, L., Chia, J.
10.1101/2021.07.09.21260106 — Posted: 2021-07-12
Impact of COVID-19 pandemic on weight and BMI among UK adults: a longitudinal analysis of data from the HEBECO study
Dicken, S. J., Mitchell, J. J., Newberry Le Vay, J., Beard, E., Kale, D., Herbec, A., Shahab, L.
10.1101/2021.07.10.21259585 — Posted: 2021-07-12
COVID-19 and Herpes Simplex Virus Infection: A Cross-Sectional Study
Shanshal, M., Ahmed, H. S.
10.1101/2021.07.09.21260217 — Posted: 2021-07-12
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial
Wanaratna, K., Leethong, P., Inchai, N., Chueawiang, W., Sriraksa, P., Tabmee, A., Sirinavin, S.
10.1101/2021.07.08.21259912 — Posted: 2021-07-11
The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes
Costello, S. M., Shoemaker, S. R., Hobbs, H. T., Nguyen, A. W., Hsieh, C.-L., Maynard, J. A., McLellan, J. S., Pak, J. E., Marqusee, S.
10.1101/2021.07.11.451855 — Posted: 2021-07-11 Discussion: Onsite
Markers of immune activation and inflammation in individuals with post-acute sequelae of SARS-CoV-2 infection
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-e., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., Chenna, A., Yee, B. C., Winslow, J. W., Petropoulos, C. J., Greenhouse, B., Hunt, P. W., Hsue, P. Y., Martin, J. N., Kelly, J. D., Glidden, D. V., Deeks, S. G., Henrich, T. J.
10.1101/2021.07.09.21260287 — Posted: 2021-07-11
A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection
Li, Y., Xu, M., Li, Y., Gu, W., Halimu, G., Li, Y., Zhang, Z., Zhou, L., Liao, H., Yao, S., Zhang, H., Zhang, C.
10.1101/2021.07.08.451596 — Posted: 2021-07-10
Using big data analytics to explore the relationship between government stringency and preventative social behaviour during the COVID-19 pandemic in the United Kingdom
Al-Zubaidy, N., Fernandez Crespo, R., Jones, S., Drikvandi, R., Gould, L., Leis, M., Maheswaran, H., Neves, A. L., Darzi, A.
10.1101/2021.07.09.21260246 — Posted: 2021-07-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).